Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.
| Last: | $12.765 |
|---|---|
| Change Percent: | 11.0% |
| Open: | $13.79 |
| Close: | $11.50 |
| High: | $14.79 |
| Low: | $12.7 |
| Volume: | 596,797 |
| Last Trade Date Time: | 03/13/2026 12:45:53 pm |
| Market Cap: | $114,325,961 |
|---|---|
| Float: | 6,045,903 |
| Insiders Ownership: | 2.03% |
| Institutions: | 33 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.korrobio.com |
| Country: | US |
| City: | Cambridge |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Korro Bio Inc. (NASDAQ: KRRO).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
